LivaNova works with holders of 3% exchangeables due 2025 on buybacks

Chicago, March 6 – LivaNova plc’s wholly owned subsidiary LivaNova USA, Inc. is working with certain holders of its 3% cash exchangeable senior notes due 2025 on expected repurchases of the notes, according to a press release.

Proceeds from a new offering, priced Tuesday, will be applied to the buybacks.

The company expects to pay $270.5 million, including accrued interest, for $230 million face amount of the notes.

The company expects to enter into separate and individually negotiated transactions that will depend on several factors, including the market price of the company’s ordinary shares and the trading price of the exchangeable senior notes at the time of the repurchase.

LivaNova is a London-based medical technology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.